Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Rocket Pharmaceuticals
Biotech
Rocket aborts mission to get rare disease gene therapy approved
Having already altered the journey of its rare disease gene therapy toward FDA approval, Rocket Pharmaceuticals has now aborted the mission entirely.
James Waldron
Oct 3, 2025 9:30am
Rocket's gene therapy free from FDA hold
Aug 20, 2025 10:40am
Rocket adjusts trajectory, laying off staff and narrowing focus
Jul 24, 2025 8:05am
Rocket crashes as gene therapy patient dies, FDA imposes hold
May 27, 2025 9:49am
Rocket's gene therapy sets new efficacy bar in ph. 1 heart study
May 16, 2025 10:36am
Rocket gene therapy's flight to approval delayed by FDA
Jun 28, 2024 9:58am